You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1a / 1b

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Large B-cell Lymphoma Trial (KITE-197, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Relapsed/Refractory Large B-cell Lymphoma
  • (no location specified)
Oct 6, 2023

Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)

Not yet recruiting
  • Pulmonary Sarcoidosis
  • XTMAB-16 or Placebo
  • (no location specified)
May 25, 2023

Cystic Fibrosis Trial in Christchurch (ABCI, Placebo)

Recruiting
  • Cystic Fibrosis
  • ABCI
  • Placebo
  • Christchurch, New Zealand
    New Zealand Clinical Research
Apr 4, 2023

Advanced Solid Tumor Trial (NB002)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jun 29, 2023

Brain Tumor Trial in Houston (tepotinib, tepotinib plus osimertinib)

Not yet recruiting
  • Brain Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Oct 27, 2023

Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)

Not yet recruiting
  • Healthy
  • H107e
  • +10 more
  • Pretoria, Gauteng, South Africa
    Aurum Institute
Sep 24, 2023

Solid Tumor Trial in Houston (IMGS-001)

Recruiting
  • Solid Tumor
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2023

Ulcerative Colitis Trial in Melbourne (LIV001, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Jul 26, 2023

Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)

Not yet recruiting
  • Chronic Hepatitis B
  • HEPLISAV B; TherVacB
  • TherVacB
  • Hamburg, Germany
    CTC North
Feb 3, 2023

Healthy Trial in Centennial (OPT101)

Active, not recruiting
  • Healthy
  • Centennial, Colorado
    IMMUNOe Research
Sep 22, 2022

Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)

Active, not recruiting
  • Alcohol Use Disorder
  • Glendale, California
    Parexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023

Advanced Solid Tumors, HER2-positive Breast Cancer Trial in United States (ZN-A-1041 50mg BID, ZN-A-1041 100mg BID, ZN-A-1041

Recruiting
  • Advanced Solid Tumors
  • HER2-positive Breast Cancer
  • ZN-A-1041 50mg BID
  • +12 more
  • Tucson, Arizona
  • +6 more
Nov 16, 2022

Cancer Trial (Antibody-Drug Conjugate)

Not yet recruiting
  • Cancer
  • Antibody-Drug Conjugate
  • (no location specified)
Aug 23, 2023

Leprosy Trial in Rio de Janeiro (LEP-F1 + GLA-SE, Placebo)

Not yet recruiting
  • Leprosy
  • LEP-F1 + GLA-SE
  • Placebo
  • Rio de Janeiro, Brazil
    Veronica Schmitz Pereira
Dec 5, 2022

Squamous Cell Carcinoma, RP1 Trial (RP1)

Not yet recruiting
  • Squamous Cell Carcinoma
  • RP1
  • (no location specified)
May 4, 2023

Advanced or Metastatic Solid Tumors Trial (PMC-309 monotherapy, PMC-309 Dose Escalation in Combination with Pembrolizumab,

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • PMC-309 monotherapy
  • +2 more
  • (no location specified)
Jul 19, 2023

Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)

Not yet recruiting
  • Decompensated Cirrhosis
  • Human Umbilical Cord-derived Mesenchymal Stem Cells
  • Beijing, China
    Beijing 302 Hospital
Aug 2, 2023

Cervical Cancer Trial in Beijing (BL-B01D1, SI-B003)

Not yet recruiting
  • Cervical Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Aug 16, 2023

Advanced Cancer, Metastatic Solid Tumor, Solid Tumor Trial (TACH101)

Recruiting
  • Advanced Cancer
  • +2 more
  • Austin, Texas
    NEXT Oncology
Jan 25, 2023

Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)

Not yet recruiting
  • Small Cell Lung Cancer
  • Changchun, Jilin, China
    Jilin Cancer Hospital
Jun 21, 2023

Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

Not yet recruiting
  • Advanced Malignancies
  • 1A46 Drug Substance
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 4, 2023

Subcutaneous Fat Trial in Omaha (CBL-514 injection, CBL-A1 Injection, CBL-A2 Injection)

Not yet recruiting
  • Subcutaneous Fat
  • CBL-514 injection
  • +3 more
  • Omaha, Nebraska
    Investigational Site 1
Aug 17, 2023

Ulcerative Colitis Trial in Whittier (APL-1401, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Whittier, California
    New Hope Research Development
Feb 15, 2023

Advanced Solid Tumor Trial (PY265, PY265 + CPI)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Sep 28, 2022